DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 64 filers reported holding DESIGN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,344,240 | -16.2% | 1,296,788 | +0.8% | 0.00% | – |
| Q1 2024 | $5,182,427 | +96.1% | 1,285,962 | +29.0% | 0.00% | – |
| Q4 2023 | $2,642,471 | +13.5% | 997,159 | +1.1% | 0.00% | – |
| Q3 2023 | $2,328,638 | -62.4% | 986,711 | +0.3% | 0.00% | – |
| Q2 2023 | $6,194,627 | -16.3% | 983,274 | -23.4% | 0.00% | – |
| Q1 2023 | $7,403,158 | -53.8% | 1,283,043 | -17.8% | 0.00% | – |
| Q4 2022 | $16,023,042 | -38.2% | 1,561,700 | +0.6% | 0.00% | -100.0% |
| Q3 2022 | $25,946,000 | +44.8% | 1,551,750 | +21.2% | 0.00% | 0.0% |
| Q2 2022 | $17,920,000 | -40.8% | 1,280,044 | -31.7% | 0.00% | 0.0% |
| Q1 2022 | $30,263,000 | -24.4% | 1,873,893 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $40,047,000 | +150.5% | 1,870,502 | +71.9% | 0.00% | – |
| Q3 2021 | $15,986,000 | -33.4% | 1,088,201 | -9.8% | 0.00% | -100.0% |
| Q2 2021 | $23,986,000 | +541.7% | 1,205,966 | +864.8% | 0.00% | – |
| Q1 2021 | $3,738,000 | – | 124,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 2,732,501 | $81,702,000 | 7.97% |
| Cormorant Asset Management, LP | 5,114,850 | $146,409,000 | 3.26% |
| Octagon Capital Advisors LP | 250,000 | $7,475,000 | 2.82% |
| EcoR1 Capital, LLC | 1,137,940 | $34,024,000 | 1.51% |
| RA Capital Management | 2,186,636 | $65,380,000 | 0.99% |
| Avoro Capital Advisors LLC | 1,468,318 | $39,702,000 | 0.69% |
| Vivo Capital, LLC | 530,991 | $15,877,000 | 0.56% |
| Rock Springs Capital Management LP | 327,250 | $9,785,000 | 0.21% |
| Artal Group S.A. | 400,000 | $11,960,000 | 0.21% |
| Baker Brothers Advisors | 1,436,636 | $42,955,000 | 0.19% |